Apr 13 (Reuters)-
Cosmos Pharmaceutical Corp.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Feb 28, 2018 Feb 28, 2017 May 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 410.77 370.57 552.40
(+10.8 pct) (+13.0 pct) (+9.9 pct)
Operating 15.78 17.37 20.00
(-9.2 pct) (+29.4 pct) (-10.1 pct)
Recurring 17.65 19.11 22.50
(-7.6 pct) (+28.0 pct) (-8.5 pct)
Net 11.87 12.58 15.30
(-5.6 pct) (+36.7 pct) (-16.0 pct)
EPS 599.73 yen 635.36 yen 772.74 yen
Ann Div 80.00 yen 90.00 yen
-Q2 div 45.00 yen 35.00 yen
-Q4 div 45.00 yen 45.00 yen
NOTE - Cosmos Pharmaceutical Corp..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T